Preeclampsia is a pregnancy-specific syndrome with multisystem involvement which leads
to foetal, neonatal, and maternal morbidity and mortality. This syndrome is characterized by …

Preeclampsia, new onset hypertension in pregnancy, affects~ 5%–10% of the world's
population. Preeclampsia is the leading cause of morbidity and mortality for both the mother …

Preeclampsia (PE) is a pregnancy-specific syndrome, characterized in general by
hypertension with proteinuria or other systemic disturbances. PE is the major cause of …

The placenta is a vital organ of pregnancy, regulating adaptation to pregnancy, gestational
parent/fetal exchange, and ultimately, fetal development and growth. Not surprisingly, in …

Preeclampsia is a devastating pregnancy disorder. Severity varies widely, and while severe
preeclampsia often requires pre-term delivery, women with mild preeclampsia may reach …

Abstract Preeclampsia complicates 5–8% of all pregnancies worldwide, and although its
pathophysiology remains obscure, placental oxidative stress and mitochondrial …

Placental ischemia is believed to be the initial event in the development of preeclampsia.
Mitochondrial dysfunction is a cause of reactive oxygen species (ROS) generation and …

Preeclampsia (PE) is a dangerous complication of pregnancy, especially when it presents
at< 34 wk of gestation (PE< 34 wk). It is a major cause of maternal and fetal morbidity and …

Aberrant placentation generating placental oxidative stress is proposed to play a critical role
in the pathophysiology of preeclampsia. Unfortunately, therapeutic trials of antioxidants have …

Mitochondria are central to cell function. The placenta forms the interface between maternal
and fetal systems, and placental mitochondria have critical roles in maintaining pregnancy …